the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences

Pharmaceutical Market Research

<< Previous Page:   5   6   7   8   9   10   11   12   13   14   15   16   Next >>
 
Pharmaceutical Distribution in the US: Current and Future Perspectives
Table of Contents Published: 2009/07 Published by: Urch Publishing, Ltd.
In the US, the pharmaceutical supply chain involves the daily delivery of approximately 13 million prescription products to pharmacies, hospitals, clinics and other healthcare provider locations. ...

Medical Tourism Market Report: 2009 Edition
Table of Contents Published: 2009/07 Published by: Koncept Analytics
This report gives an overview of the medical tourism industry with focus on Asia. It discusses the major medical tourist destinations like Singapore, Thailand, Malaysia, India, Philippines, Taiwan and South Korea and their respective competitive advantage ...

CEO 360 Degree Perspective - Global Pharmaceuticals & Biotechnology Industry
Table of Contents Published: 2009/07 Published by: Frost & Sullivan
This research service presents the CEO 360 Degree Perspective for the global pharmaceuticals and biotechnology industry in 2009. It is an amalgamation of research from more than 50 Pharmaceutical research services generated by Frost & Sullivan, customer r ...

Generic Drugs: The Global Market
Table of Contents Published: 2009/07 Published by: BCC Research
The aim of this report is to provide detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription generic drugs. Important trends are identified and sales forecasts by product categories and major cou ...

Commercial Insight: Antihypertensives - New fixed dose combinations unable to stem the tide of patent expiries
Table of Contents Published: 2009/07 Published by: Datamonitor
Following the patent expiries of ARBs Datamonitor expects antihypertensives sales in the seven major markets to record sales of $29.5 billion in 2018, a drop of over $6 billion compared to 2008. With no promising novel pipeline agents, pharmaceutical comp ...

Generics Series: Authorized Generics Analysis
Table of Contents Published: 2009/07 Published by: Datamonitor
While the benefits of authorized generics to the branded industry are clearly apparent, the attitude of the generics industry is determined by individual company strategy. ...

Commercial Insight: Psoriasis - Intellectual property drives growth
Table of Contents Published: 2009/07 Published by: Datamonitor
The launch of new brands in both biologic and topical treatments in 2009 is shaking up the psoriasis market. Stelara (ustekinumab; Johnson & Johnson) is eagerly anticipated by dermatologists, and Datamonitor forecast strong uptake. However, the threat of ...

Biosimilars and Biobetters: Positioning for a New Market
Table of Contents Published: 2009/07 Published by: Biophoenix Limited
This new and timely report analyzes the emerging market for first- and second-generation biosimilars. The market can best be understood in the context of the established $110 billion biologics business, which is therefore comprehensively reviewed. Current ...

United Arab Emirates Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
The UAE Ministry of Health is planning to establish a National Pharmocovigilance Committee in Q309. ...

Spain Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
Spainfs pharmaceutical market, valued at EUR15.3bn in 2008, is expected to be cushioned from the impact of the global financial crisis in the short term, with BMI forecasting nominal drug market expenditure growth of 6% in euros between 2008 and 2009. ...

Moldova Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
Moldovafs pharmaceutical market was valued at only US$242mn in 2008, making the country of minimal attractiveness to all but the most pan-European multinational pharmaceutical companies. ...

Hungary Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
BMI has downgraded its forecast for Hungaryfs US$3.28bn pharmaceutical market after the macroeconomic climate deteriorated further in Q209. ...

Dealmaking and Industry Outlook: Autoimmune and Inflammatory Diseases
Table of Contents Published: 2009/07 Published by: Decision Resources, Inc.
Better diagnostics, the means to treat earlier stage-disease, disease-modifying therapies, and disease prevention are the holy grails of autoimmune and infl ammatory disease drug development. However, basic science and redundant biological pathways are ho ...

Merck & Co. Inc: PharmaVitae Profile
Table of Contents Published: 2009/07 Published by: Datamonitor
This analysis examines the historical and forecast performance for Merck & Co. in the Rx pharmaceutical sector. ...

Pipeline and Commercial Insight: Obesity - The $11 billion market that never was
Table of Contents Published: 2009/07 Published by: Datamonitor
The obesity market is easily characterized as attractive, featuring a booming patient potential needing long term therapy, but repeated product withdrawals and failed pipeline candidates highlight the reality of increasingly cautious regulatory bodies, re ...

Bariatric (Obesity) Surgical Devices
Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc.
This report analyzes the US and European markets for Bariatric (Obesity) Surgical Devices in Millions of US$. The US market for Bariatric Surgical Devices is analyzed by the following segments: Gastric Bypass Devices, and Gastric Banding Devices. ...

Lung Cancer Therapeutics
Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc.
This report analyzes the worldwide markets (Annual Revenues) for Lung Cancer Therapeutics in Millions of US$. The US market for Non-Small Cell Lung Cancer treatment is further analyzed by: Chemotherapy Drugs, and Targeted Drugs. ...

Brachytherapy
Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc.
This report analyzes the Global Market for Brachytherapy in Millions of US$. The eBrachytherapy' market is analyzed in terms of the following product segments: Implantable Prostate Seeds Brachytherapy, and Post-Operative Brachytherapy. Annual forecasts a ...

Autoimmune Disease Therapeutics
Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc.
This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Billion by the following therapeutic class - Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Crohn' s Disease (Biologics only), and Others. The report provides sepa ...

Prescription Drugs
Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc.
This report analyzes the worldwide markets for Prescription Drugs in US$ Billion by the following therapeutic class -Oncologics/ Cancer Drugs, Lipid Regulators, Respiratory Agents, Proton Pump Inhibitors, Antidiabetics, Antipsychotics, Antidepressants, An ...

Small Molecule Kinase Inhibitors
Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc.
This report analyzes the Global Market for Small Molecule Kinase Inhibitors in Millions of US$ by the following Product Segments: Gleevec/Glivec, Tarceva, Sutent, Nexavar, Sprycel, Iressa, Tykerb/Tyverb, and Others. ...

Nanomedicine
Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc.
This report analyzes the Global Market for Nanomedicine in Millions of US$ by the following Application Areas: Drug Delivery, In Vitro Diagnostics, In Vivo Imaging, Biomaterials, and Others. Annual forecasts are provided for the period of 2006 through 201 ...

Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics, 2nd edition
Table of Contents Published: 2009/07 Published by: CurrentPartnering, a division of Wildwood Ventures Limited
The Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the worlds leading biopharma companies ...

The Psychiatric Disease Pipeline: A Strategic Review
Table of Contents Published: 2009/07 Published by: Decision Resources, Inc.
Numbers tell the story in psychiatric disease drug development: almost 300 recognized indications, 28% 12-month prevalence that yields large patient populations, strong 7.5% annual sales growth in recent years, sustained franchise sales, tolerance for use ...

Managing Sales Training to Accelerate Speed to Productivity
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
Though effective sales training is a valuable investment, it is being cut back out of economic necessity. Given this reality and the fluctuation of company needs and competitive pressures, training roles and responsibilities, resources, contents and evalu ...

Best Practices in Designing Effective Brand Teams: Brand Governance and Brand Team Management
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
Designing Effective Brand Teams: Brand Governance and Brand Team Management explores how high-performing brand teams coordinate, communicate, and execute critical activities to drive brand growth. It yields insights into how pharmaceutical and biotech com ...

Managed Markets Market Research: Effective Structures & Activities for Gaining Maximum Payer Access & Insight
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
Commercial success of pharmaceutical products today depends increasingly upon understanding the needs of the commercial and government payers in the highly-influential Managed Markets sector. In response, savvy bio-pharmaceutical companies are seeking to ...

The Top 10 Pharmaceutical Companies in India: Growth strategies, performance and SWOT analyses
Table of Contents Published: 2009/07 Published by: Business Insights
The Top 10 Pharmaceutical Companies in India' examines the leading players in the Indian pharmaceutical market comprising both India-based and multinational companies. This report analyzes the Indian pharmaceutical industry in terms of market size, key d ...

The Chinese Hospital Pharmaceutical Market Outlook To 2014: Policy environment, healthcare system, market structure, competitive landscape, growth opportunities
Table of Contents Published: 2009/07 Published by: Business Insights
The Chinese Hospital Pharmaceutical Market Outlook to 2014' provides comprehensive coverage of the Chinese pharmaceutical market, reviewing the market structure, pricing and regulation, and includes detailed epidemiological analyses of the common risk fac ...

The Vaccines Market Outlook To 2014: Competitive landscape, pipeline analysis, growth opportunities and market forecasts
Table of Contents Published: 2009/07 Published by: Business Insights
The $11.1bn global vaccines market demonstrated flat y-o-y growth in 2008 as per IMS Health. The combination of new biotechnology research techniques and manufacturing technologies have created a new vibrant vaccine business. ...

MicroRNA Diagnostics, Therapeutics, and Cancer Personalized Medicine 2009 Market Report
Table of Contents Published: 2009/07 Published by: Select Biosciences, Ltd.
This is the latest and most up-to-date Market Analysis Report from Select Biosciences addressing MicroRNA Diagnostics, Therapeutics and Cancer Personalized Medicine. The Cancer Personalized Medicine Marketplace Provides a Paradigm for the development of M ...

Colorectal Cancer Drug Discoveries: what the future holds
Table of Contents Published: 2009/07 Published by: Espicom Business Intelligence
The worldwide incidence of colorectal cancer (CRC) is approximately one million cases per year and, in the US, it is the third most common cancer in both sexes, accounting for around 8.5 per cent of all cancer deaths. ...

U.S. CRO Markets - Key Therapeutic Areas
Table of Contents Published: 2009/07 Published by: Frost & Sullivan
This research service provides a detailed overview and analysis of key therapeutic areas in the U.S. CRO Market. The research service includes a detailed analysis of market trends, industry challenges and key therapeutic areas. Revenue forecasts from 2010 ...

Forecast Insight: Attention-Deficit Hyperactivity Disorder - Shire to stay on top despite drug safety fears and generic competition
Table of Contents Published: 2009/07 Published by: Datamonitor
Driven primarily by continued uptake of Shire' s market leading ADHD drug, Adderall XR (amphetamine extended release), seven major market ADHD revenues grew strongly at a compound annual growth rate (200408) of 13.5% to reach almost $4.4 billion in 2008. ...

Pipeline and Commercial Insight: Osteoporosis Novel agents to battle for payer acceptance
Table of Contents Published: 2009/07 Published by: Datamonitor
Osteoporosis continues to be an attractive therapy area for large pharmaceutical companies due to its high prevalence rate and unmet need. Globally, sales for osteoporosis drugs grew 7.0% year-on-year from 2004 to $9.6 billion in 2008 driven by strong per ...

F. Hoffmann-La Roche Ltd.: PharmaVitae Profile
Table of Contents Published: 2009/07 Published by: Datamonitor
This analysis examines the historical and forecast performance for Roche in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sal ...

Strategic Analysis of U.S. Molecular Cytogenetics Markets
Table of Contents Published: 2009/07 Published by: Frost & Sullivan
This research service provides a strategic analysis of the molecular cytogenetics market within the United States. The research service covers market trends, technology trends, competitive structure, market share analysis, and revenue forecasts. The key c ...

Ukraine Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
This report presents Ukraine Pharmaceuticals and Healthcare Report Q3 2009. ...

Switzerland Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
This report presents Switzerland Pharmaceuticals and Healthcare Report Q3 2009. ...

Portugal Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
This report presents Portugal Pharmaceuticals and Healthcare Report Q3 2009. ...

Malaysia Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
This report presents Malaysia Pharmaceuticals and Healthcare Report Q3 2009. ...

Indonesia Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
This report presents Indonesia Pharmaceuticals and Healthcare Report Q3 2009. ...

Chile Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
This report presents Chile Pharmaceuticals and Healthcare Report Q3 2009. ...

Brazil Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
In terms of emerging pharmaceutical markets, Brazil remains one of the most attractive to multinational pharmaceutical companies operating in the Americas. ...

Belgium Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
In BMIfs latest pharmaceutical market report for Belgium, we are forecasting flat value growth for Belgiumfs pharmaceutical market. ...

Optimizing Key Opintion Leader Relationships: Best Practices in KOL Management
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
This report identifies the organizational structures, management strategies and tactics, and critical success factors associated with KOL management excellence. Pharma executives can use this benchmarking research to learn best practices in KOL management ...

Medical Science Liaisons: Gaining Access and Forging Relationships with Key Opinion Leaders
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
As companies compete for the attention of physicians, key opinion leaders (KOLs) and thought leaders, they increasingly use medical science liaisons (MSLs) to build and strengthen KOL relationships. As laws continue to restrict relationships between pharm ...

Using Public Relations to Launch, Grow and Extend Your Brands
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
This Best Practices, LLC benchmarking report identifies the most current and effective PR tools and calls-to-action, and explores how top companies align these tactics with each stage of a product' s lifecycle. Pharmaceutical executives and directors can ...

Building an Effective Regulatory Relationship with the FDA
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
This report delivers benchmarks and insights that identify approaches for understanding and effectively interacting with the FDA. The research is based on detailed survey data from Regulatory Affairs executives and managers from 15 top pharmaceutical comp ...

Strategic Analysis of U.S. Drugs of Abuse Laboratory Testing Service Markets
Table of Contents Published: 2009/07 Published by: Frost & Sullivan
This research service analyzes drugs of abuse laboratory testing services within the United States. The market is further divided into three distinct sub-segments. Each segment covers key market drivers and restraints, market trends, technology trends, co ...


<< Previous Page:   5   6   7   8   9   10   11   12   13   14   15   16   Next >>

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.